PDS Biotechnology (PDSB) Competitors $3.22 +0.03 (+0.94%) (As of 03:43 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends PDSB vs. SELB, INO, VALN, SIGA, AQST, ALT, PRTC, ALEC, XERS, and AVXLShould you be buying PDS Biotechnology stock or one of its competitors? The main competitors of PDS Biotechnology include Selecta Biosciences (SELB), Inovio Pharmaceuticals (INO), Valneva (VALN), SIGA Technologies (SIGA), Aquestive Therapeutics (AQST), Altimmune (ALT), PureTech Health (PRTC), Alector (ALEC), Xeris Biopharma (XERS), and Anavex Life Sciences (AVXL). These companies are all part of the "medical" sector. PDS Biotechnology vs. Selecta Biosciences Inovio Pharmaceuticals Valneva SIGA Technologies Aquestive Therapeutics Altimmune PureTech Health Alector Xeris Biopharma Anavex Life Sciences PDS Biotechnology (NASDAQ:PDSB) and Selecta Biosciences (NASDAQ:SELB) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, dividends, community ranking, analyst recommendations, earnings, risk, valuation, institutional ownership and media sentiment. Does the media refer more to PDSB or SELB? In the previous week, PDS Biotechnology had 1 more articles in the media than Selecta Biosciences. MarketBeat recorded 1 mentions for PDS Biotechnology and 0 mentions for Selecta Biosciences. PDS Biotechnology's average media sentiment score of 0.00 equaled Selecta Biosciences'average media sentiment score. Company Overall Sentiment PDS Biotechnology Neutral Selecta Biosciences Neutral Which has better earnings & valuation, PDSB or SELB? Selecta Biosciences has higher revenue and earnings than PDS Biotechnology. PDS Biotechnology is trading at a lower price-to-earnings ratio than Selecta Biosciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPDS BiotechnologyN/AN/A-$42.94M-$1.22-2.71Selecta Biosciences$110.78M0.00$35.38M-$0.22N/A Do insiders and institutionals hold more shares of PDSB or SELB? 26.8% of PDS Biotechnology shares are held by institutional investors. Comparatively, 42.0% of Selecta Biosciences shares are held by institutional investors. 9.5% of PDS Biotechnology shares are held by company insiders. Comparatively, 31.2% of Selecta Biosciences shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Is PDSB or SELB more profitable? PDS Biotechnology has a net margin of 0.00% compared to Selecta Biosciences' net margin of -72.04%. Selecta Biosciences' return on equity of -44.13% beat PDS Biotechnology's return on equity.Company Net Margins Return on Equity Return on Assets PDS BiotechnologyN/A -137.06% -66.12% Selecta Biosciences -72.04%-44.13%-22.00% Which has more volatility and risk, PDSB or SELB? PDS Biotechnology has a beta of 1.9, suggesting that its share price is 90% more volatile than the S&P 500. Comparatively, Selecta Biosciences has a beta of 0.84, suggesting that its share price is 16% less volatile than the S&P 500. Do analysts recommend PDSB or SELB? PDS Biotechnology presently has a consensus target price of $14.25, suggesting a potential upside of 335.78%. Given PDS Biotechnology's higher probable upside, equities analysts clearly believe PDS Biotechnology is more favorable than Selecta Biosciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score PDS Biotechnology 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 3.20Selecta Biosciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/A Does the MarketBeat Community prefer PDSB or SELB? Selecta Biosciences received 263 more outperform votes than PDS Biotechnology when rated by MarketBeat users. However, 70.10% of users gave PDS Biotechnology an outperform vote while only 55.63% of users gave Selecta Biosciences an outperform vote. CompanyUnderperformOutperformPDS BiotechnologyOutperform Votes6870.10% Underperform Votes2929.90% Selecta BiosciencesOutperform Votes33155.63% Underperform Votes26444.37% SummaryPDS Biotechnology and Selecta Biosciences tied by winning 8 of the 16 factors compared between the two stocks. Ad Weiss RatingsAmerica dodged a crisis — next time it could be much worseLegendary financial forecaster, Dr. Martin Weiss, has been warning us about it for months … He believes the next incident could lead to people seeing their bank accounts frozen.Click here and follow the three simple steps Martin shares in this video to protect your savings whi Get PDS Biotechnology News Delivered to You Automatically Sign up to receive the latest news and ratings for PDSB and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PDSB vs. The Competition Export to ExcelMetricPDS BiotechnologyPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$121.87M$7.06B$5.30B$8.52BDividend YieldN/A7.92%5.06%4.15%P/E Ratio-2.716.3498.4613.04Price / SalesN/A390.651,485.5491.33Price / CashN/A47.4338.8434.18Price / Book3.945.574.715.08Net Income-$42.94M$153.29M$117.71M$225.39M7 Day Performance6.09%-1.38%-0.48%0.10%1 Month Performance-9.32%15.21%5.86%4.01%1 Year Performance-20.81%42.41%37.38%32.40% PDS Biotechnology Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PDSBPDS Biotechnology0.8407 of 5 stars$3.22+0.9%$14.25+342.5%-23.5%$118.56MN/A-2.6420SELBSelecta BiosciencesN/AN/AN/AN/A$136.76M$110.78M-4.0164Analyst ForecastGap DownHigh Trading VolumeINOInovio Pharmaceuticals3.515 of 5 stars$5.67+1.3%$43.80+672.5%-89.9%$146.92M$591,858.000.00127VALNValneva1.5503 of 5 stars$6.11+2.9%$18.50+202.8%-50.7%$496.44M$165.52M-11.75700SIGASIGA Technologies2.829 of 5 stars$6.95+2.7%N/A+41.6%$496.02M$139.92M5.9440Upcoming EarningsOptions VolumeAQSTAquestive Therapeutics1.5966 of 5 stars$5.44-0.9%$8.83+62.4%+249.7%$495.25M$58.36M-15.54160Upcoming EarningsNews CoverageALTAltimmune1.8239 of 5 stars$6.90+3.1%$18.80+172.5%+179.7%$490.38M$430,000.00-4.2650Upcoming EarningsPRTCPureTech Health2.9108 of 5 stars$20.39+2.0%$45.00+120.7%+13.1%$487.93M$3.33M0.00100Gap UpALECAlector4.2686 of 5 stars$5.01+5.3%$17.75+254.3%-5.4%$482.89M$55.28M-2.78270Upcoming EarningsXERSXeris Biopharma4.1354 of 5 stars$3.24+1.3%$4.67+44.0%+76.0%$482.76M$163.91M-7.53290News CoverageAVXLAnavex Life Sciences3.3941 of 5 stars$5.57+6.3%$40.00+618.1%+18.6%$471.46MN/A-11.1440News CoverageGap Up Related Companies and Tools Related Companies SELB Competitors INO Competitors VALN Competitors SIGA Competitors AQST Competitors ALT Competitors PRTC Competitors ALEC Competitors XERS Competitors AVXL Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:PDSB) was last updated on 11/1/2024 by MarketBeat.com Staff From Our PartnersEx-Lawyer turns $50k into $5 million tradingHe was a lawyer by day, secret trader by night...or in this case by lunch… With nothing but a laptop and a ...Investing Daily | SponsoredBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | SponsoredHe made 1,303,329 in 12 months after Biden won…Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredThe real reason Elon is fully endorsing TrumpElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | SponsoredCapitalize on Generational Opportunities in the ‘Roaring 2020s’The industrial revolutions in our country's past have connected the world in ways never thought possible… C...Unstoppable Prosperity | SponsoredIf You’re Even Thinking of Investing in AI, Read This First.If you're starting to invest in AI or even just thinking about it, it can feel overwhelming and even a bit sca...Brownstone Research | Sponsored4 Trades for $4?! (Next Pick Goes LIVE Tues!)Bryan wants show you his unique trading philosophy... It allows his members to take profits early again and...Monument Traders Alliance | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PDS Biotechnology Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share PDS Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.